History of Heart Failure Definition

Raluca Ibănescu1,2,3, Diana-Alexandra Mîțu1,2,3, Iacob-Daniel Goje1,2,3

  • 1Advanced Cardiology and Haemostaseology Research Centre, Victor Babeș University of Medicine and Pharmacy Timișoara, Romania.

PubMed

Insights

The definition of heart failure (HF) has evolved from early observations to a complex clinical syndrome. Modern understanding integrates pathophysiology and diagnostics, improving patient care and outcomes.

Area of Science:

  • Cardiology
  • Medical History

Background:

  • Heart failure (HF) understanding has evolved significantly over centuries.
  • Early medical insights from ancient civilizations and the Renaissance laid foundational knowledge.
  • The 20th century marked a turning point with formal definitions and diagnostic criteria for HF.

Purpose of the Study:

  • To trace the historical evolution of heart failure definitions.
  • To highlight key milestones in understanding HF's pathophysiology and diagnosis.
  • To emphasize how evolving definitions improve patient outcomes.

Main Methods:

  • Historical analysis of medical texts and seminal studies.
  • Review of diagnostic criteria and conceptual shifts in heart failure.
  • Integration of advancements in pathophysiology, biomarkers, and imaging.

Main Results:

  • Early concepts focused on symptoms; modern definitions emphasize structural/functional cardiac abnormalities.
  • The Framingham Heart Study was pivotal in formally defining HF.
  • Evolving definitions reflect increased diagnostic precision and therapeutic advancements.

Conclusions:

  • The historical progression of HF definitions enhances diagnostic accuracy.
  • Refined understanding of HF leads to improved therapeutic strategies.
  • Appreciating HF's evolution is key for current management and future research.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.2K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
284
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
445